\-\ Texto\\:\\ \ \(0\)\
\-\ unremarkable\\ pe\\ and\\ laboratory\\ results\ \(0\)\
\-\ discontinue\\ use\\ of\\ oral\\ contraceptives\ \(0\)\
\-\ 2cm\\ mass\\ in\\ liver\\ showing\\ hyperattenuation\\ during\\ early\\ \\(arterial\\)\\ phase\\ of\\ contrast\\ enhanced\\ ct\\ and\\ isoattenuation\\ during\\ late\\ \\(portal\\ venous\\)\\ phase\\.\ \(0\)\
\-\ hypervascular\\ hepatic\\ mass\\:\\ possible\\ hepatic\\ adenoma\ \(0\)\
\-\ hepatic\\ adenoma\ \(5\)\
\-\ focal\\ nodular\\ hyperplasia\ \(9\)\
\-\ hepatic\\ hemangioma\ \(3\)\
\-\ hypervascular\\ metastasis\ \(0\)\
\-\ hepatocellular\\ carcinoma\ \(28\)\
\-\ healthy\\ 34\\ y\\/o\\ female\\ taking\\ ocps\\ referred\\ for\\ triphasic\\ liver\\ scan\\ following\\ incidental\\ discovery\\ of\\ hepatic\\ mass\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ hepatic\\:\\ 0\\.2478121077643064\ \(0\)\
\-\ hypervascular\\:\\ 0\\.1403977307853593\ \(0\)\
\-\ isoattenuation\\:\\ 0\\.1128107117139799\ \(0\)\
\-\ phase\\:\\ 0\\.11165910773249324\ \(0\)\
\-\ triphasic\\:\\ 0\\.10717925187914427\ \(0\)\
\-\ discontinue\\:\\ 0\\.10318366753953621\ \(0\)\
\-\ adenoma\\:\\ 0\\.09912484310572256\ \(0\)\
\-\ hyperattenuation\\:\\ 0\\.09755220770470059\ \(0\)\
\-\ ocps\\:\\ 0\\.09541122604043312\ \(0\)\
\-\ contraceptives\\:\\ 0\\.09355662336509253\ \(0\)\
\-\ discovery\\:\\ 0\\.08392957919064883\ \(0\)\
\-\ liver\\:\\ 0\\.0818394864120201\ \(0\)\
\-\ 2cm\\:\\ 0\\.07666224386058568\ \(0\)\
\-\ during\\:\\ 0\\.07263914583121689\ \(0\)\
\-\ hepatocellular\\:\\ 0\\.06838469619244265\ \(0\)\
\-\ taking\\:\\ 0\\.06303961534653393\ \(0\)\
\-\ portal\\:\\ 0\\.06247264320041928\ \(0\)\
\-\ late\\:\\ 0\\.061750980159714954\ \(0\)\
\-\ 34\\:\\ 0\\.05890010340920993\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.0584770588608112\ \(0\)\
\-\ showing\\:\\ 0\\.05462106251916843\ \(0\)\
\-\ healthy\\:\\ 0\\.05350935824592487\ \(0\)\
\-\ pe\\:\\ 0\\.05331645391036005\ \(0\)\
\-\ hemangioma\\:\\ 0\\.053032029863921984\ \(0\)\
\-\ arterial\\:\\ 0\\.05194923067684265\ \(0\)\
\-\ enhanced\\:\\ 0\\.05078421006599957\ \(0\)\
\-\ oral\\:\\ 0\\.05000809258829878\ \(0\)\
\-\ nodular\\:\\ 0\\.04978346954322099\ \(0\)\
\-\ mass\\:\\ 0\\.04951920862281518\ \(0\)\
\-\ results\\:\\ 0\\.04791031123534231\ \(0\)\
\-\ use\\:\\ 0\\.04690887659782365\ \(0\)\
\-\ incidental\\:\\ 0\\.044941508305281604\ \(0\)\
\-\ referred\\:\\ 0\\.0447851589368839\ \(0\)\
\-\ metastasis\\:\\ 0\\.04442704619861009\ \(0\)\
\-\ laboratory\\:\\ 0\\.04373738522019536\ \(0\)\
\-\ early\\:\\ 0\\.0434049856894783\ \(0\)\
\-\ venous\\:\\ 0\\.043080355811904565\ \(0\)\
\-\ possible\\:\\ 0\\.039971975262278775\ \(0\)\
\-\ unremarkable\\:\\ 0\\.03929258914836195\ \(0\)\
\-\ focal\\:\\ 0\\.033895744501922245\ \(0\)\
\-\ following\\:\\ 0\\.03368441329029372\ \(0\)\
\-\ carcinoma\\:\\ 0\\.033637884305775925\ \(0\)\
\-\ scan\\:\\ 0\\.03322599250601359\ \(0\)\
\-\ y\\/o\\:\\ 0\\.0328698476363839\ \(0\)\
\-\ contrast\\:\\ 0\\.02656632898344313\ \(0\)\
\-\ female\\:\\ 0\\.024399448214553244\ \(0\)\
\-\ \\(\\:\\ 0\\.020065603506773902\ \(0\)\
\-\ \\)\\:\\ 0\\.019820491447591806\ \(0\)\
\-\ ct\\:\\ 0\\.01660143963044504\ \(0\)\
\-\ \\:\\:\\ 0\\.01569826133320368\ \(0\)\
\-\ for\\:\\ 0\\.010126502064482153\ \(0\)\
\-\ in\\:\\ 0\\.00585273930750354\ \(0\)\
\-\ and\\:\\ 0\\.00500025015922829\ \(0\)\
\-\ of\\:\\ 0\\.004854325033249517\ \(0\)\
\-\ \\.\\:\\ 0\\.0009860982249262854\ \(0\)\
